TOC 6th page

438 Caroline Nilsson, MD, Annika Linde, MD, PhD, Scott M. Montgomery, BSc, PhD, Liselotte Gustafsson, Per Näsman, Ph Lic, Marita Troye Blomberg, PhD, and Gunnar Lilja, MD, PhD, Stockholm, Sweden Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis445 Heather A. Coker, PhD, Helen E. Harries, MBiochem, Graham K. Banfield, FRCS, Victoria A. Carr, RGN, Stephen R. Durham, MD, Elfy Chevretton, FRCS, Paul Hobby, MSc, Brian J. Sutton, PhD, and Hannah J. Gould, PhD, London, United Kingdom Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis453 Til Menge, MD, Patrice H. Lalive, MD, Hans-Christian von Büdingen, MD, Bruce Cree, MD, PhD, Stephen L. Hauser, MD, and Claude P. Genain, MD, San Francisco, Calif, and Zürich, Switzerland Letters to the Editor Perilesional GM-CSF therapy of a chronic leg ulcer in a patient with common variable immunodeficiency460 Ammar Z. Hatab, MD, Deanna McDanel, PharmD, BCPS, and Zuhair K. Ballas, MD, Iowa City, Iowa Asthma caused by cyanoacrylate used in a leisure activity462 Mona-Rita Yacoub, MD, Catherine Lemière, MD, MSc, and Jean-Luc Malo, MD, Montreal, Quebec, Canada Correspondence Cystic fibrosis gene mutations and chronic rhinosinusitis463 Clement L. Ren, MD, Rochester, NY Leukotriene receptor antagonists are not as effective as intranasal corticosteroids for managing nighttime symptoms of allergic rhinitis463 Robert A. Nathan, MD, Colorado Springs, Colo Efficacy of ant venom immunotherapy and whole body extracts464 Simon G. A. Brown, MBBS, PhD, FACEM, Robert J. Heddle, MBBS, PhD, FRACP, FRCPA, Michael D. Wiese, BPharm, MClinPharm, and Konrad E. Blackman, MBBS, FACEM, Fremantel, Bedford Park, and Hobart, Australia Reply465 David B. K. Golden, MD, Baltimore, Md Images in allergy and immunology Toll-like receptors and atopy467 Pierre Olivier Fiset, BSc, Meri Katarina Tulic, PhD, and Qutayba Hamid, MD, PhD, Editors